CIPLA -Rising wedge Breakout
CIPLA-Rising -Rising wedge Breakout
Name - CIPLA
Pattern - Rising wedge
Status - BreakOut with good volume
Cmp - 1654
Target - 1850
SL - 1600
Pattern
A rising wedge pattern is a technical analysis tool that often signals a potential bearish reversal. It forms when the price of an asset is moving upward, but the trendlines converge, indicating a loss of momentum. When the price breaks below the lower trendline, it typically suggests a downward move.
Fundamentals :
Here are some key financial ratios for Cipla Limited:
Price-to-Earnings (PE) Ratio: 28.71
Debt-to-Equity Ratio: 0.021
Return on Equity (ROE): 16.8%1
Net Profit Margin: 16.5%2
Revenue Growth (TTM): 10.3%2
Enterprise Value to EBITDA: 19.813
Price-to-Sales Ratio: 4.943
These ratios indicate Cipla’s strong financial health, low leverage, and efficient profitability. The company is well-positioned in the pharmaceutical industry with a solid market presence.
Name - CIPLA
Pattern - Rising wedge
Status - BreakOut with good volume
Cmp - 1654
Target - 1850
SL - 1600
Pattern
A rising wedge pattern is a technical analysis tool that often signals a potential bearish reversal. It forms when the price of an asset is moving upward, but the trendlines converge, indicating a loss of momentum. When the price breaks below the lower trendline, it typically suggests a downward move.
Fundamentals :
Here are some key financial ratios for Cipla Limited:
Price-to-Earnings (PE) Ratio: 28.71
Debt-to-Equity Ratio: 0.021
Return on Equity (ROE): 16.8%1
Net Profit Margin: 16.5%2
Revenue Growth (TTM): 10.3%2
Enterprise Value to EBITDA: 19.813
Price-to-Sales Ratio: 4.943
These ratios indicate Cipla’s strong financial health, low leverage, and efficient profitability. The company is well-positioned in the pharmaceutical industry with a solid market presence.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.